UBS Group
GOVX icon

UBS Group’s GeoVax Labs GOVX Stock Holding History

UBS Group’s Portfolio GOVX Stock Details GOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2K Sell
944
-3,304
-78% -$5.02K ﹤0.01% 9610
2026
Q1 		$5.86K Buy
4,248
+668
+19% +$1.6K ﹤0.01% 8737
2025
Q4 		$15.3K Buy
3,580
+1,243
+53% +$13.7K ﹤0.01% 7966
2025
Q3 		$27.6K Sell
2,337
-5,673
-71% -$99.2K ﹤0.01% 7949
2025
Q2 		$173K Buy
8,010
+4,351
+119% +$108K ﹤0.01% 6816
2025
Q1 		$97K Buy
3,659
+2,526
+223% +$111K ﹤0.01% 7070
2024
Q4 		$69.9K Buy
1,133
+1,087
+2,363% +$62.9K ﹤0.01% 7082
2024
Q3 		$2.75K Buy
+46
New +$3.87K ﹤0.01% 8373
2023
Q4 		– Sell
-51
Closed -$9.78K – 9532
2023
Q3 		$9.78K Buy
51
+49
+2,450% +$10.3K ﹤0.01% 7122
2023
Q2 		$399 Sell
2
-37
-95% -$8.85K ﹤0.01% 8255
2023
Q1 		$9.71K Buy
+39
New +$10.9K ﹤0.01% 7630
2022
Q3 		– Sell
-11
Closed -$4K – 10558
2022
Q2 		$4K Buy
+11
New +$4.85K ﹤0.01% 9069
2022
Q1 		– Sell
-12
Closed -$16K – 10492
2021
Q4 		$16K Buy
12
+7
+140% +$10.4K ﹤0.01% 8159
2021
Q3 		$8K Buy
+5
New +$8.71K ﹤0.01% 8198
2021
Q1 		– Sell
-5
Closed -$7K – 9180
2020
Q4 		$7K Buy
+5
New +$5.82K ﹤0.01% 7687

Other funds holding GOVX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

UBS Group's GOVX Position: Q2 2026 in Review

UBS Group reduced its GeoVax Labs (GOVX) stake by 78% in Q2 2026, selling an estimated $5.02K and leaving 944 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #9610.

UBS Group first reported a position in GOVX in Q4 2020 and has held it in 15 quarters since. The position peaked at $173K in Q2 2025. 11 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

  • UBS Group held 944 shares of GeoVax Labs worth $1.2K as of Q2 2026.
  • UBS Group sold 3,304 GeoVax Labs shares in Q2 2026, an estimated $5.02K.
  • GeoVax Labs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9610 holding.
  • UBS Group first reported a position in GeoVax Labs in Q4 2020 and has held it in 15 quarters since.
  • UBS Group's GeoVax Labs position peaked at $173K in Q2 2025.
  • 11 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.